147 related articles for article (PubMed ID: 7726538)
1. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
Karyotakis NC; Dignani MC; Hachem R; Anaissie EJ
Antimicrob Agents Chemother; 1995 Feb; 39(2):571-3. PubMed ID: 7726538
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK
Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of D0870 treatment of experimental Candida vaginitis.
Fidel PL; Cutright JL; Sobel JD
Antimicrob Agents Chemother; 1997 Jul; 41(7):1455-9. PubMed ID: 9210665
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
Graybill JR; Najvar LK; Holmberg JD; Luther MF
Antimicrob Agents Chemother; 1995 Apr; 39(4):924-9. PubMed ID: 7785997
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of D0870 against murine infections and its mechanism of action.
Yamada H; Tsuda T; Watanabe T; Kusakabe S; Mochizuki H
Chemotherapy; 1998; 44(2):112-20. PubMed ID: 9551242
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
Pfaller MA; Bale MJ; Buschelman B; Rhomberg P
Diagn Microbiol Infect Dis; 1994 Jun; 19(2):75-80. PubMed ID: 7805359
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antifungal activities of D0870, a new triazole agent.
Yamada H; Tsuda T; Watanabe T; Ohashi M; Murakami K; Mochizuki H
Antimicrob Agents Chemother; 1993 Nov; 37(11):2412-7. PubMed ID: 8285626
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal activities of D0870 against fluconazole-resistant Candida albicans].
Kojima M; Yamada H; Nakamura S; Kikuchi M; Nakanishii T; Takahashi Y; Mochizuki H; Mikami Y
Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):209-15. PubMed ID: 10536307
[TBL] [Abstract][Full Text] [Related]
9. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
[TBL] [Abstract][Full Text] [Related]
10. SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Karyotakis NC; Dignani MC; Anaissie EJ
Antimicrob Agents Chemother; 1995 Mar; 39(3):775-7. PubMed ID: 7793892
[TBL] [Abstract][Full Text] [Related]
11. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
[TBL] [Abstract][Full Text] [Related]
12. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
Anaissie E; Gokaslan A; Hachem R; Rubin R; Griffin G; Robinson R; Sobel J; Bodey G
Clin Infect Dis; 1992 Nov; 15(5):781-7. PubMed ID: 1445976
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.
Kamberi P; Atsuro H; Takayoshi T; Masaru N
Chemotherapy; 1998; 44(1):55-62. PubMed ID: 9444410
[TBL] [Abstract][Full Text] [Related]
14. Activities of the triazole D0870 in vitro and against murine blastomycosis.
Clemons KV; Hanson LH; Stevens DA
Antimicrob Agents Chemother; 1993 May; 37(5):1177-9. PubMed ID: 8517710
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
[TBL] [Abstract][Full Text] [Related]
17. Colorimetric MTT assessment of antifungal activity of D0870 against fluconazole-resistant Candida albicans.
Yang HC; Mikami Y; Yazawa K; Taguchi H; Nishimura K; Miyaji M; Branchini ML; Aoki FH; Yamamoto K
Mycoses; 1998 Dec; 41(11-12):477-80. PubMed ID: 9919890
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
Kamai Y; Harasaki T; Fukuoka T; Ohya S; Uchida K; Yamaguchi H; Kuwahara S
Antimicrob Agents Chemother; 2002 Feb; 46(2):367-70. PubMed ID: 11796343
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice.
Karyotakis NC; Anaissie EJ
Antimicrob Agents Chemother; 1994 Nov; 38(11):2660-2. PubMed ID: 7872764
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G
J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
